Clinical Trial Update: A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints [Phase 4]

View source ↗

Summary

Phase 4 trial update of EGb 761 (Tanakan) in memory complaints and dementia of Alzheimer type.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Memory Impairment
• Dementia of Alzheimer Type
• Memory Disorders

Drugs mentioned

• EGb 761® (Tanakan®) (ginkgo biloba extract)

Snippet

Sponsor: Ipsen | Conditions: Memory Disorders, Age-Related, Retention Disorders, Cognitive | Phase 4 | Status: COMPLETED